Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating Runx2

Cells Tissues Organs

Volumn 196, Issue 6, 2012, Pages 510-522

  Sun, Jing ^a   Zhou, Huifang ^a   Deng, Yuan ^a   Zhang, Yidan ^a   Gu, Ping ^a   Ge, Shengfang ^a   Fan, Xianqun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bone marrow mesenchymal stem cell; Conditioned medium; Osteoblast differentiation; Osteogenesis

Indexed keywords

ALKALINE PHOSPHATASE; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CALVARIA; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; RATS;

RATTUS;

EID: 84870253806     PISSN: 14226405     EISSN: 14226421     Source Type: Journal    
DOI: 10.1159/000339245     Document Type: Article

References (37)

1. Aggarwal, S., M.F. Pittenger (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
2. Caplan, A.I. (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347. (Pubitemid 47509711)
3. Caplan, A.I, J.E. Dennis (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084. (Pubitemid 44128350)
4. Chen, H., F.Y. Ghori-Javed, et al (2011) Chondrocyte-specific regulatory activity of runx2 is essential for survival and skeletal development. Cells Tissues Organs 194: 161-165.
5. Chun-mao, H., W. Su-yi, et al (2007) Human bone marrow-derived mesenchymal stem cells differentiate into epidermal-like cells in vitro. Differentiation 75: 292-298.
6. Deans, R.J., A.B. Moseley (2000) Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 28: 875-884.
7. Erices, A., P. Conget, et al (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242. (Pubitemid 30340601)
8. Fei, Y., L. Xiao, et al (2011) FGF2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the WNT pathway. J Biol Chem 286: 40575-40583.
9. Feng, Z., Y. Shen, et al (2011) An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. Int J Mol Sci 12: 2543-2555.
10. Franchimont, N., V. Gangji, et al (1997) Interleukin-6 with its soluble receptor enhances the expression of insulin-like growth factor-I in osteoblasts. Endocrinology 138: 5248-5255. (Pubitemid 27509685)
11. Frank, O., M. Heim, et al (2002) Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 85: 737-746. (Pubitemid 34462784)
12. Gilbert, L., X. He, et al (2002) Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277: 2695-2701. (Pubitemid 34953297)
13. Gronthos, S., D.M. Franklin, et al (2001) Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189: 54-63.
14. Guo, J., G.S. Lin, et al (2007) Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation 30: 97-104. (Pubitemid 46985774)
15. Guo, Z., C. Zheng, et al (2009) Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells. Eur J Immunol 39: 2840-2849.
16. Hass, R., C. Kasper, et al (2011) Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9: 12.
17. Horwitz, E.M. (2006) MSC: A coming of age in regenerative medicine. Cytotherapy 8: 194-195. (Pubitemid 43947784)
18. Javed, A., F. Afzal, et al (2009) Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs 189: 133-137.
19. Kadow-Romacker, A., J.E. Hoffmann, et al (2009) Effect of mechanical stimulation on osteoblast- and osteoclast-like cells in vitro. Cells Tissues Organs 190: 61-68.
20. Kasten, P., J. Vogel, et al (2006) Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs 183: 68-79. (Pubitemid 44610330)
21. Kitajima, I., Y. Soejima, et al (1996) Ceramideinduced nuclear translocation of NF-kappa B is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone 19: 263-270. (Pubitemid 26302610)
22. Kuno, H., S.M. Kurian, et al (1994) Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: Structural determinants within the vitamin D response element. Endocrinology 134: 2524-2531. (Pubitemid 24170866)
23. Lee, H. L., T. Yi, et al (2010) Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med 42: 437-445.
24. Majumdar, M.K., M. Keane-Moore, et al (2003) Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10: 228-241. (Pubitemid 36302404)
25. Majumdar, M.K., M.A. Thiede, et al (2000) Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9: 841-848. (Pubitemid 32110282)
26. Nakashima, K., X. Zhou, et al (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29. (Pubitemid 34137009)
27. Pittenger, M.F., A.M. Mackay, et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
28. Pratap, J., M. Galindo, et al (2003) Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res 63: 5357-5362. (Pubitemid 37139851)
29. Ramasamy, R., H. Fazekasova, et al (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83: 71-76. (Pubitemid 46104974)
30. Spaggiari, G.M., H. Abdelrazik, et al (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583.
31. Sun, H., C. Wu, et al (2006) Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials 27: 5651-5657. (Pubitemid 44294824)
32. Taguchi, Y., M. Yamamoto, et al (1998) Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. Proc Assoc Am Physicians 110: 559-574. (Pubitemid 28516131)
33. Xiao, C., H. Zhou, et al (2011) Bone marrow stromal cells with a combined expression of BMP-2 and VEGF-165 enhanced bone regeneration. Biomed Mater 6: 015013.
34. Yeh, L.C., M.C. Zavala, et al (2002) Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation. J Cell Physiol 190: 322-331. (Pubitemid 34111973)
35. Zhang, J., S. Huang, et al (2010) Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3 - -UTR microRNA. Int J Cancer 126: 2229-2239.
36. Zhang, H., B. Niu, et al (2011) Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II. J Cell Biol 193: 475-487.
37. Zhou, H., C. Xiao, et al (2011) In vivo efficacy of bone marrow stromal cells coated with betatricalcium phosphate for the reconstruction of orbital defects in canines. Invest Ophthalmol Vis Sci 52: 1735-1741.